Furthermore, treatment with Abemaciclib markedly mitigated YAP1 protein levels and exhibited a substantial tumor-suppressive effect in HCC cells reconstituted with DUB3 WT. This evidence concerns the gene YAP1 and hepatocellular carcinoma.